CPIX
CUMBERLAND PHARMACEUTICALS INC
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$4.44
+3.02%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.58x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.81x
- Price / sales
- 2.13x
- Price / cash flow
- 89.18x
Enterprise value
- Enterprise value
- $67.0M
- EV / sales
- 2.14x
- EV / EBITDA
- -13.21x
- EV / EBIT
- -6.96x
- Market cap
- $66.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026